Borman A, Johnson E
Clin Microbiol Rev. 2023; 36(4):e0009922.
PMID: 37930182
PMC: 10732072.
DOI: 10.1128/cmr.00099-22.
Giordano A, Di Landro F, De Carolis E, Criscuolo M, Dragonetti G, Fianchi L
J Fungi (Basel). 2021; 7(9).
PMID: 34575816
PMC: 8466501.
DOI: 10.3390/jof7090778.
Dear J, Reagan K, Hulsebosch S, Li C, Munro M, Byrne B
J Vet Intern Med. 2021; 35(5):2232-2240.
PMID: 34387899
PMC: 8478049.
DOI: 10.1111/jvim.16244.
Mouhajir A, Matray O, Giraud S, Mely L, Marguet C, Sermet-Gaudelus I
J Clin Microbiol. 2016; 54(11):2804-2812.
PMID: 27605712
PMC: 5078560.
DOI: 10.1128/JCM.01462-16.
Warnock D
J Clin Microbiol. 2016; 55(1):53-59.
PMID: 27307456
PMC: 5228262.
DOI: 10.1128/JCM.00829-16.
Imaging characteristics of disseminated Geosmithia argillacea causing severe diskospondylitis and meningoencephalomyelitis in a dog.
Kawalilak L, Chen A, Roberts G
Clin Case Rep. 2015; 3(11):901-6.
PMID: 26576269
PMC: 4641471.
DOI: 10.1002/ccr3.372.
Indoor Fungal Exposure and Allergic Respiratory Disease.
Osborne N, Thornton C, Sharpe R
Curr Allergy Asthma Rep. 2015; 15(12):71.
PMID: 26492877
DOI: 10.1007/s11882-015-0572-7.
Distribution of Keratinophilic Fungi in Soil Across Tunisia: A Descriptive Study and Review of the Literature.
Anane S, Al-Yasiri M, Normand A, Ranque S
Mycopathologia. 2015; 180(1-2):61-8.
PMID: 25690159
DOI: 10.1007/s11046-015-9870-9.
Validation of a novel real-time PCR for detecting Rasamsonia argillacea species complex in respiratory secretions from cystic fibrosis patients.
Steinmann J, Giraud S, Schmidt D, Sedlacek L, Hamprecht A, Houbraken J
New Microbes New Infect. 2014; 2(3):72-8.
PMID: 25356347
PMC: 4184661.
DOI: 10.1002/nmi2.44.
Rasamsonia pulvericola sp. nov., isolated from house dust.
Tanney J, Seifert K
IMA Fungus. 2014; 4(2):205-12.
PMID: 24563833
PMC: 3905939.
DOI: 10.5598/imafungus.2013.04.02.06.
Clinical and microbiological efficacy of micafungin on Geosmithia argillacea infection in a cystic fibrosis patient.
Marguet C, Favennec L, Matray O, Bertout S, Giraud S, Couderc L
Med Mycol Case Rep. 2013; 1(1):79-81.
PMID: 24371745
PMC: 3854624.
DOI: 10.1016/j.mmcr.2012.08.004.
Isolation and identification of Geosmithia argillacea from a fungal ball in the lung of a tuberculosis patient.
Sohn J, Jang M, Lee J, Park K, Ki C, Lee N
Ann Lab Med. 2013; 33(2):136-40.
PMID: 23483122
PMC: 3589640.
DOI: 10.3343/alm.2013.33.2.136.
Rasamsonia argillacea pulmonary and aortic graft infection in an immune-competent patient.
Doyon J, Sutton D, Theodore P, Dhillon G, Jones K, Thompson E
J Clin Microbiol. 2012; 51(2):719-22.
PMID: 23241382
PMC: 3553912.
DOI: 10.1128/JCM.02884-12.
Taxonomy and antifungal susceptibility of clinically important Rasamsonia species.
Houbraken J, Giraud S, Meijer M, Bertout S, Frisvad J, Meis J
J Clin Microbiol. 2012; 51(1):22-30.
PMID: 23077129
PMC: 3536228.
DOI: 10.1128/JCM.02147-12.
Identification of clinical mold isolates by sequence analysis of the internal transcribed spacer region, ribosomal large-subunit D1/D2, and β-tubulin.
Jang J, Lee J, Ki C, Lee N
Ann Lab Med. 2012; 32(2):126-32.
PMID: 22389879
PMC: 3289777.
DOI: 10.3343/alm.2012.32.2.126.
Rasamsonia, a new genus comprising thermotolerant and thermophilic Talaromyces and Geosmithia species.
Houbraken J, Spierenburg H, Frisvad J
Antonie Van Leeuwenhoek. 2011; 101(2):403-21.
PMID: 21965082
PMC: 3261388.
DOI: 10.1007/s10482-011-9647-1.
Aspergillus species and other molds in respiratory samples from patients with cystic fibrosis: a laboratory-based study with focus on Aspergillus fumigatus azole resistance.
Mortensen K, Jensen R, Krogh Johansen H, Skov M, Pressler T, Howard S
J Clin Microbiol. 2011; 49(6):2243-51.
PMID: 21508152
PMC: 3122734.
DOI: 10.1128/JCM.00213-11.
Geosmithia argillacea: an emerging cause of invasive mycosis in human chronic granulomatous disease.
de Ravin S, Challipalli M, Anderson V, Shea Y, Marciano B, Hilligoss D
Clin Infect Dis. 2011; 52(6):e136-43.
PMID: 21367720
PMC: 3049339.
DOI: 10.1093/cid/ciq250.
Emergence of disseminated infections due to Geosmithia argillacea in patients with chronic granulomatous disease receiving long-term azole antifungal prophylaxis.
Machouart M, Garcia-Hermoso D, Rivier A, Hassouni N, Catherinot E, Salmon A
J Clin Microbiol. 2011; 49(4):1681-3.
PMID: 21270214
PMC: 3122873.
DOI: 10.1128/JCM.02456-10.
Clinical significance of microbial infection and adaptation in cystic fibrosis.
Hauser A, Jain M, Bar-Meir M, McColley S
Clin Microbiol Rev. 2011; 24(1):29-70.
PMID: 21233507
PMC: 3021203.
DOI: 10.1128/CMR.00036-10.